1. In just 1yr, we saw a ~55% enrollment growth among full-benefit duals and >68% among partial duals into C-SNPs.
2. About 1 in 4 duals in 2025 C-SNPs came from plans w/ some form of integration.
3. About 15% of C-SNPs could be terminated if CMS applied “look-alike” rule
Rapid growth of “Chronic Condition Special Needs Plans (C-SNPs)” enrolling dual-eligibles.
We argue their growth is threatening national integrated care efforts for duals.
www.healthaffairs.org/do/10.1377/f...
by José F. Figueroa — Reposted by: Michael Barnett
Some welcome relief hopefully to so many.
Story below:
www.thecrimson.com/article/2025...
Reposted by: José F. Figueroa
“I always told myself the stress of dealing with insurance was worse than the cancer.”
Insights from patients w/ cancer dealing with prior authorizations in @jamanetworkopen.com study
jamanetwork.com/journals/jam...
by José F. Figueroa — Reposted by: Ellen Meara
It’s a predictable result when you cut off insurance to people who are old, poor and sick.
Eric Roberts @pennldi.bsky.social and I discuss @msnbc.com @harvardhpm.bsky.social
www.msnbc.com/opinion/msnb...
A bipartisan group of House and Senate lawmakers considering finally fixing the MA to VA cost-shifting loophole that currently leads to billions in MA profits to provide zero care while VA foots the bill.
Story by @wsj.com
www.wsj.com/politics/pol...
Veterans in high-veteran MA plans are much more likely to have surgical care paid by VA than plan itself—even when surgery occurs in non-VA hospitals…
Reposted by: José F. Figueroa, Stacie B. Dusetzina
#ARM25 @academyhealth.bsky.social
https://ja.ma/4jKGy6e
Forum brings together a diverse set of people working on issues related to improving health.
Full list of @aspenideas.bsky.social Health Fellows:
www.aspenideas.org/articles/202...
by José F. Figueroa — Reposted by: José F. Figueroa
We estimate that this will lead to over 18,000 avoidable deaths per year stemming from loss of drug subsidies
Link to our memo led by @pennldi.bsky.social:
bit.ly/4mwfcDA
@pennldi.bsky.social @harvardhpm.bsky.social
Link to study: www.nejm.org/doi/full/10....
by José F. Figueroa — Reposted by: Rachel C. Nethery
This week, we are forced to reckon with what’s next, including shutting down research portfolios, considering staffing cuts, and scrambling to cover salaries.
HSPH: “ground zero” of NIH cuts
www.nytimes.com/2025/05/21/u...
Link to study 2, which is our @nejm.org study led by Eric Roberts: www.nejm.org/doi/full/10....
1) Value of having Medicaid (Wyse & Meyer, NBER)
2) Human costs of losing Medicaid & linked subsidized drug coverage in @nejm.org
Lives saved in study 1 and lives lost in study 2
www.npr.org/sections/sho...
Urgent need for VA and CMS to fix this inefficiency to tune of $BILLIONS per year.
1. No significant differences in total utilization or spending of dental & vision services between vets in MA vs TM.
2. MA plans only spend ~$82 per veteran enrollee on dental care and ~$6 more on vision aids than what TM vets get.
MA insurers argue that vets get extra benefits (vision + dental).
But in new @jama.com study, we find that this claim is NOT actually the truth.
@adambeckman.bsky.social @hsph.harvard.edu
jamanetwork.com/journals/jam...
Reposted by: José F. Figueroa, Michael Barnett, Ellen Meara
https://ja.ma/3ZficKj
by Ellen Meara — Reposted by: José F. Figueroa
How important is help with drug costs? For dual Medicare-Medicaid beneficiaries, it saves lives.
Reposted by: José F. Figueroa, Michael Barnett, Ellen Meara , and 1 more José F. Figueroa, Michael Barnett, Ellen Meara, John A. Graves
Medicare saves lives. But is it enough to save lives of the most vulnerable Americans? The study suggests no; Medicaid still matters. (1/11)
Reposted by: José F. Figueroa
Reposted by: José F. Figueroa, Michael Barnett
Here's the punchline: "Loss of drug subsidies after Medicaid disenrollment was associated with higher mortality among low-income Medicare beneficiaries."
www.nejm.org/doi/full/10....
Reposted by: José F. Figueroa
(Standard disclaimer that AHRQ is an agency created and funded by Congress, not at the whims of the executive branch)
hsph.harvard.edu/news/hiv-car...
In new @JAMANetwOpen study, we show rates of filling older, toxic ART among PWH has substantially declined to near zero in favor of newer/preferred ART regimens.
jamanetwork.com/journals/jam...
@harvardhpm.bsky.social @hsph.harvard.edu
He’s been an incredible chair that has guided & grown the department for nearly 3 decades, and we will all miss him as our chair…
@harvardhpm.bsky.social
“Without broader participation, ACO REACH is unlikely to achieve its goal of reducing health inequities.”
jamanetwork.com/journals/jam...